CROs raise the alarm as clients delay R&D plans over funding, tariff worries
Contract research organizations Icon and Medpace have both reported high rates of canceled or delayed R&D projects on the back of the Trump administration's funding cuts and potential sector-specific tariffs. On Wednesday, Icon
